Global Healthcare Leader Deploys QUOSA's Literature Management Tools

Global Healthcare Leader DeploysGlobal Healthcare Leader Deploys QUOSA's Literature Management Tools PR Newswire PHILADELPHIA, October 22, 2013 Sanofi will use QUOSA, part of Elsevier Life Science Solutions for drug discovery and development, to support adverse event monitoring Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Sanofi, one of the world's leading pharmaceutical organizations, has implemented QUOSA's literature management tools to automate adverse event monitoring. QUOSA powers the retrieval, storage, tagging and annotation of relevant case reports, allowing for the creation of a centralized repository of product- related scientific literature. This centralized repository supports Sanofi's Pharmacovigilance team in drug safety and adverse event monitoring, ensuring patient safety and compliance with regulatory reporting requirements in all the markets in which it operates. "Pharmaceutical companies are continually challenged to ensure regulatory compliance is met. This is no easy task with limited resources, an ever- growing number of literature articles and an increasing portfolio of drugs to be tracked. Left untamed, this presents significant risks in compliance and crucially, in patient safety," said Michael Rai, General Manager of QUOSA at Elsevier.